The anionic compounds, aurintricarboxylic acid, Evans blue, glycyrrhizic acid, taurolithocholic acid, and fuchsin acid, have been tested for their capacity to inhibit the replication of African swine fever virus (ASFV) in Vero cells. Aurintricarboxylic acid suppressed ASFV cytopathic effects at 5μg ml−1 and emerged as the most efficacious inhibitor with a selectivity index (S.I.) of 400, followed by Evans blue with 40, Fuchsin acid with 20, taurolithocholic acid with 10, and glycyrrhizic acid with 5.
All the compounds inhibited the virus adsorption or penetration to the cells in some degree, but inhibition was also found when they were added after virus adsorption, indicating that other mechanism (or mechanisms) are involved in viral inhibition.
References
1.
AlcamiA.CarrascosaA.L., and VinuelaE. (1989) Saturable binding sites mediate the entry of African swine fever virus into Vera cells. Virology168: 393–398.
2.
ArzuzaO.García-VillalónD.TabarésE.Gil-FernándezC., and De ClercqE. (1988) Inhibition of African swine fever virus DNA synthesis by (S)-9-(3-hydroxy-2-phosphonylmethoxyprppyl)adenine. Bioch and Bioph Res Commum154: 27–32.
3.
BabaM., and ShigetaS. (1987) Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro. Antiviral Res7: 99–107.
4.
BabaM.ScholsD.PauwelsR.BalzariniJ., and De ClercqE. (1988) Fuchsin acid selectively inhibits human immunodeficiency virus (HIV) replication in vitro. Biochem and Biophys Res Commum155: 1404–1411.
5.
BalzariniJ.MitsuyaH.De ClercqE., and BroderS. (1986) Aurintricarboxylic acid and Evans blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III lymphadenopathy-associated virus. Biochem Biophys Res Commum136: 64–71.
6.
BlumenthalT., and LandersT.A. (1973) The inhibition of nucleic acid-binding proteins by aurintricarboxylic acid. Biochem Biophys Res Commum55: 680–688.
7.
CranceJ.M.BiziagosE.PassagotH.J.van Cuyck-GrandréH., and DeloinceR. (1990) Inhibition of hepatitis A virus replication in vitro by antiviral compounds. J Med Virol31: 155–160.
8.
DardiriA.H.BachrachH.L., and HellerE. (1971) Inhibition by rifampin of African swine fever virus replication in tissue culture. Infect and Immun4: 34–36.
9.
de BoerC.J. (1967) Studies to determine neutralizing antibody in sera from animals recovered from African swine fever and laboratory animals inoculated with African virus with adjuvants. Arch Ges Virusforsch20: 164–179.
10.
De ClercqE. (1989) New acquisitions in the development of anti-HIV agents. Antiviral Res12: 1–20.
11.
EnjuanesL.CarrascosaA.L.MorenoM.A., and ViñuelaE. (1976) Titration of African swine fever (ASF) virus. J Gen Virol32: 479–492.
12.
GeraldesA., and ValdeiraM.L. (1985) Effect of chloroquine on African swine fever virus infection. J Gen Virol66: 1145–1148.
13.
García-VillalónD., and Gil-FernándezC. (1991) Antiviral activity of sulfated polysaccharides against African swine fever virus. Antiviral Res15: 139–148.
14.
Gil-FernándezC., and De ClercqE. (1987a) Comparative efficacy of broad-spectrum antiviral agents as inhibitors of African swine fever virus replication in vitro. Antiviral Res7: 151–160.
15.
Gil-FernándezC.García-VillalónD.De ClercqE.RosenbergI., and HolyA. (1987b) Phosphonylmethoxyalkylpurines and -pyrimidines as inhibitors of African swine fever virus replication in vitro. Antiviral Res8: 273–282.
16.
Gil-FernéndezC.PáezE.VilasP., and García-GancedoA. (1979) Effect of disodium phosphonoacetate and iododeoxyuridine on the multiplication of African swine fever virus in vitro. Chemotherapy25: 162–169.
17.
Gil-FernándezC.PerezS.VilasP.de las HerasF.G., and García-GancedoA. (1987c) Antiviral activity of uridine-5 diphosphate glucose analogues against some enveloped viruses in cell culture. Antiviral Res8: 299–310.
18.
GivensJ.F., and ManlyK.F. (1976) Inhibition of RNA-directed DNA polymerase by aurintricarboxylic acid. Nucleic Acids Res3: 405–418.
19.
GrollmanA.P., and StewartM.L. (1968) Inhibition of the attachment of messenger ribonucleic acid to ribosomes. Proc Natl Acad Sci USA61: 719–725.
20.
HaagJ.LarenaudieB., and GonzalvoF.R. (1965) Peste porcine Africaine, action de la 5-iodo-2′-desoxyuridine sur la culture du virus in vitro. Bull Off Int Epizoot63: 717–722.
21.
HessW.R. (1981) African swine fever: a reassessment. Adv Vet Sci Comp Med25: 39–69.
22.
HuangM.T., and GrollmanA.P. (1972) Effects of aurintricarboxylic acid on ribosomes and the biosynthesis of globin in rabbit reticulocytes. Mol Pharmacol8: 111–127.
23.
ItoM.NakashimaH.BabaM.PauwelsR.De ClercqE.ShigetaS., and YamamotoN. (1987) Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)]. Antiviral Res7: 127–137.
24.
ItoM.SatoA.HirabayashiK.TanabeF.ShigetaS.BabaM.De ClercqE.NakashimaH., and YamamotoN. (1989) Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV). Antiviral Res10: 289–298.
25.
KihmU.AckermannM.MuellerH.PoolR. (1987) Approaches to vaccination. In: African swine fever.BeckerY. (ed.). Martinus Nijhoff, Boston, pp. 127–144.
26.
LeisJ.P., and HurwitzJ. (1972) RNA-dependent DNA polymerase activity of RNA tumor viruses. J Virol9: 130–142.
27.
LiaoL.L.HorwitzS.B.HuangM.T., and GrollmanA.P. (1975) Triphenylmethane dyes as inhibitors of reverse transcriptase, ribonucleic acid polymerase, and protein synthesis. Structure-activity relationships. J Med Chem18: 117–120.
28.
MorenoM.A.CarrascosaA.L.OrtinJ., and VinuelaE. (1978) Inhibition of African swine fever (ASF) virus replication by phosphonoacetic acid. J Gen Virol93: 253–258.
29.
PompeiR.FloreO.MarccialisM.A.PaniA., and LoddoB. (1979) Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature281: 689–690.
30.
GonzalvoF. RuizCarneroM.E.CaballeroC., and MartinezJ. (1986) Inhibition of African swine fever infection in the presence of immune sera in vivo and in vitro. Am J Vet Res47: 1249–1252.
31.
ScholsD.BabaM.PauwelsR.DesmyterJ., and De ClercqE. (1989) Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus CD4 cell receptor. Proc Natl Acad Sci USA86: 3322–3326.
32.
SiegelmanF., and ApirionD. (1971) Aurintricarboxylic acid, a preferential inhibitor of initiation of protein synthesis. J of Bacteriol105: 902–907.
33.
SolaA.RodriguezS.García-GancedoA.VilasP., and Gil-FernándezC., (1986a) Inactivation and inhibition of African swine fever virus by monoolein, monolinolein and γ-linolenyl alcohol. Arch Virol88: 285–292.
34.
SolaA.RodriguezS.Gil-FernándezC.AlarcónB.GonzalezM.E., and CarrascoL. (1986b) New agents active against African swine fever virus. Antimicrob Agents Chemother29: 284–288.
35.
StewartM.L.GrollmanA.P., and HuangM.T. (1971) Aurintricarboxylic acid: inhibitor of initiation of protein synthesis. Proc Natl Acad Sci USA68: 97–101.
36.
VillingerF.GenovesiE.V.GerstnerD.J.WhyardT.C., and KnudsenR.C. (1990) Inhibition of African swine fever virus in cultured swine monocytes by phosphonoacetic acid (PAA) and by phosphonoformic acid (PFA). Arch Virol115: 163–184.
